Skip to content

Evidence

Automated quantification and localization of white matter hyperintensities in FLAIR MRI to support disease risk stratification and longitudinal assessment

ECR: Poster Presentation
Moeskops et al. 2026

 

White matter hyperintensities (WMHs) are clinically actionable imaging markers of several neurological conditions, including cognitive impairment and multiple sclerosis (MS). Manual segmentation of WMHs on Fluid-Attenuated Inversion Recovery (FLAIR) MRI is time-consuming and impractical for routine clinical practice, limiting consistent use in risk stratification and longitudinal assessment. This study evaluates an AI algorithm for automated quantification and localization by identifying, segmenting, and labelling anatomical location of WMHs.

Disclaimers: DeepHealth Prostate is manufactured as Quantib Prostate by Quantib BV for DeepHealth Inc., DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc., DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc. and DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us